600.16 Impact of Restrictive Versus Obstructive Pulmonary Disease in Patients with Chronic Lung Disease Undergoing Transcatheter Aortic Valve Replacement
| Autor: | Jacinda Berg, Hugh A. Cassiere, Alan R. Hartman, Pey-Jen Yu, Michael A. Catalano, Dishen Lin, Bruce Rutkin, Gregory Maurer |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Vital capacity
medicine.medical_specialty Transcatheter aortic business.industry medicine.medical_treatment Pulmonary disease respiratory system respiratory tract diseases FEV1/FVC ratio Valve replacement Lung disease Internal medicine Cardiology Medicine In patient Risk factor Cardiology and Cardiovascular Medicine business |
| Zdroj: | JACC: Cardiovascular Interventions. 12:S47-S48 |
| ISSN: | 1936-8798 |
| DOI: | 10.1016/j.jcin.2019.01.168 |
| Popis: | Chronic lung disease, as defined by forced expiratory volume in 1 second (FEV1) < 75% of predicted, is an independent risk factor for poor outcomes in transcatheter aortic valve replacement (TAVR). The purpose of this study is to determine if the use of forced vital capacity (FVC) to differentiate |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|